投融资
AI Integration in Single-Use Technologies Reshapes Biopharmaceutical Manufacturing as Global Corporate AI Investment Reaches $252.3 Billion
AI Integration in Single-Use Technologies Reshapes Biopharmaceutical Manufacturing as Global Corporate AI Investment Reaches $252.3 Billion
摘要: “AI and single-use technologies are converging to make biopharmaceutical manufacturing faster, smarter and more adaptive.”......
正文
“AI and single-use technologies are converging to make biopharmaceutical manufacturing faster, smarter and more adaptive.”...